What is the avarage maximum MB of the plant/animal genome that can be de novo sequenced with GAIIx? Is there a limit?
Unconfigured Ad
Collapse
X
-
Theoretically there isn't a limit. If you want to run enough lanes you can sequence anything you could do with a HiSeq - it would just work out more expensive.
We've recently worked out costing for sequencing a ~400Mbp genome using a GAIIx. You basically need to use one whole flowcell for this whereas on a HiSeq you'd only need 3 lanes (and would actually get higher coverage from those, but the amount of data from the GA would be more than enough). In this case the costs on a HiSeq would be cheaper than the GA, but not ridiculously so. Once your genome gets much bigger than this I can't see the GA being economic.
If you're mostly going to be focussed on genome sequencing, even of smallish genomes then I'd be looking at a HiSeq rather than a GA. In our case the genome sequencing is an unusual run, so the GA works well for us still.
-
We'll do mostly small RNAs and mRNA-seq, but we have one plan to seq a plant woth ~1000MB genome.
Just for info what was the overall total cost of consumables for your 400MB genome on GAIIx? and how many runs you did it with?
Thanks!------------
SMART - bioinfo.uni-plovdiv.bg
Comment
-
If it's just a one off it would be worth finding out what it would cost to outsource this to a sequencing service. You could still do all of the library prep in house if you wanted and just get them to do the sequencing.Originally posted by vebaev View PostWe'll do mostly small RNAs and mRNA-seq, but we have one plan to seq a plant woth ~1000MB genome.
I don't have the break down to hand. The costs we had were full costings including staff time, instrument depreciation and all sorts of other stuff in addition to the cost of reagents.Originally posted by vebaev View PostJust for info what was the overall total cost of consumables for your 400MB genome on GAIIx? and how many runs you did it with?
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-06-2026, 07:41 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
08-06-2026, 07:41 AM
|
||
|
Started by SEQadmin2, 08-03-2026, 10:13 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
08-03-2026, 10:13 AM
|
||
|
Started by SEQadmin2, 07-31-2026, 02:55 AM
|
0 responses
40 views
0 reactions
|
Last Post
by SEQadmin2
07-31-2026, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
Comment